Skip to content

Clinical trials

Anemia, Sickle Cell trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Country / region: Lebanon Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20122
20133
20141
20152
20162
20171
20184
20193
20201
20215
20226
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated10
Recruiting4
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
AstraZeneca4
Novartis Pharmaceuticals4
Forma Therapeutics, Inc.3
Novo Nordisk A/S3
HemaQuest Pharmaceuticals Inc.2
Hoffmann-La Roche2
Sangart2
Agios Pharmaceuticals, Inc.1
Cardurion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell35
Vaso-Occlusive Crises11
Hematologic Diseases6
Sickle Cell Trait5
Anemia3
Anemia, Hemolytic2
Genetic Diseases, Inborn2
Hemoglobin SC Disease2
Hemoglobinopathies2
Hemolysis2

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.